DelveInsight’s, “Anaplastic Thyroid Cancer Pipeline Insight 2025,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline ...

Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge.

Explore expert, evidence-based insights on medullary carcinoma of the thyroid and colon, including diagnosis and targeted therapies.

Recent research found that weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer overdiagnosis. Here's why.

CHICAGO — In patients with stage IVB anaplastic thyroid cancer, the inclusion of adjuvant pembrolizumab to conventional multimodal therapy shows significant benefits in reducing the recurrence ...

Support for the study of anaplastic thyroid carcinoma came from Genentech, the Rare Tumor Initiative, the University of Texas MD Anderson Cancer Center, and NIH.

The symptoms of thyroid cancer that has spread to other areas depends on its location. Learn more here.

Anaplastic thyroid cancer is a rare and fast-growing disease. Learn what causes it and its symptoms, diagnosis, and treatments.

While BRAF mutations are the most common genetic alterations in thyroid cancer, other mutations can be present and introduce challenges for thyroid cancer treatment. Though they are less frequent, RET ...

Overall survival rates for adults diagnosed with anaplastic thyroid carcinoma are similar between those with a history of cancer and those with no previous cancer diagnosis, according to findings ...